WHO Statement on Depot-Medroxyprogesterone Acetate (DMPA)

WHO Statement on Depot-medroxyprogesterone acetate (DMPA) The purpose of this Statement is to reiterate and clarify the existing (current) WHO position based on published guidance that is still valid. WHO monitors the evidence in this field closely and will update its...

Advocates Call for Full Funding of Research on HIV and Contraception

Advocates Call for Full Funding of Research on HIV and Contraception By Lillian Mworeko & Emily Bass A commentary by AIDS Legal Network South Africa, ATHENA Network, AVAC, International Community of Women Living with HIV/AIDS-East Africa, Pangaea Zimbabwe AIDS...

Hormonal Contraceptive Methods for Women at High Risk of HIV and Living with HIV

Hormonal Contraceptive Methods for Women at High Risk of HIV and Living with HIV 2014 Guidance Statement In addition to the recommendations themselves, this publication provides a description of the background and methods used in their development.    ...

Webinar: Contraception and HIV: What Do the Evidence and WHO Technical Statement Mean for Programs?

Webinar: Contraception and HIV: What Do the Evidence and WHO Technical Statement Mean for Programs? In June 2013 FHI 360 and USAID hosted a webinar about the evidence and current technical guidance on hormonal contraception and HIV, and what they mean for programs in...

Use of Injectable Contraceptive and HIV Acquisition: The Data to Date

Use of Injectable Contraceptive and HIV acquisition: The Data to Date This graphic summarizes the results of studies that gathered information on the relationships between injectable hormonal contraceptives and HIV as of 2013.       Published: 2013...